Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair Proficient Stage II Colon Cancer

PURPOSE: Prognostic markers that identify patients with stage II colon cancers (CC) who are at risk of recurrence are essential to personalize therapy. We evaluated the potential of GIV/Girdin as a predictor of recurrence risk in such patients. EXPERIMENTAL DESIGN: Expression of full-length GIV was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Ghosh, Pradipta, Tie, Jeanne, Muranyi, Andrea, Singh, Shalini, Brunhoeber, Patrick, Leith, Katherine, Bowermaster, Rebecca, Liao, Zhiming, Zhu, Yifei, LaFleur, Bonnie, Tran, Ben, Desai, Jayesh, Jones, Ian, Croxford, Matthew, Jover, Rodrigo, Goel, Ajay, Waring, Paul, Hu, Song, Teichgraeber, Volker, Rohr, Ulrich-Peter, Ridder, Ruediger, Shanmugam, Kandavel, Gibbs, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4947424/
https://ncbi.nlm.nih.gov/pubmed/27029492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados